Highlights
KLSE: SCOMNET (0001)       SUPERCOMNET TECHNOLOGIES BHD ACE : Health Care
Last Price Today's Change   Day's Range   Trading Volume
1.79   +0.01 (0.56%)  1.76 - 1.80  367,600
Trade this stock for as low as 0.05% brokerage. Find out more.

Overview

Market Cap: 1,352 Million
NOSH: 755 Million
Avg Volume (4 weeks):1,178,526
4 Weeks Range:1.72 - 1.91
4 Weeks Price Volatility (%):
36.84%
52 Weeks Range:1.39 - 2.37
52 Weeks Price Volatility (%):
40.82%
Average Price Target: 2.68
Price Target Upside/Downside: +0.89

Financial Highlight

Latest Quarter | Ann. Date 30-Jun-2021 [#2]  |  27-Aug-2021
Next QR | Est. Ann. Date: 30-Sep-2021  |  30-Nov-2021
T4Q P/E | EY: 59.20  |  1.69%
T4Q DY | Payout %: 0.74%  |  43.73%
T4Q NAPS | P/NAPS: 0.3729  |  4.80
T4Q NP Margin | ROE: 15.59%  |  8.11%

Headlines

Date Subject
27-Sep-2021 Market Chat - 4Q21 Outlook & Strategy - Recovery begins with an ENDemic
23-Sep-2021 Daily Market Update - 23 Sept 2021 (SCOMNET, FITTERS)
13-Sep-2021 Stocks on Radar - Supercomnet Technologies (0001)
01-Sep-2021 Technical Tracker - SCOMNET: Brace for a stronger 2H21
01-Jul-2021 3利好扶持 半导体业突围可期
23-Jun-2021 Daily technical highlights – (SOLUTN, SCOMNET)
16-Apr-2021 Trading Stocks - Supercomnet Technologies
24-Mar-2021 Technical View - Supercomnet Technologies Bhd
14-Mar-2021 业绩亮丽或未及预期 神通网络WA吸引力低/温世麟
16-Feb-2021 Potentially Super Growth in 2021
07-Jan-2021 Mplus Market Pulse - 7 Jan 2021
06-Jan-2021 Sector And Sub-Sector Update : Supercomnet Technologies Berhad
18-Dec-2020 Technical View- SCOMNET (0001)
27-Nov-2020 Daily technical highlights – (ARBB, SCOMNET)

Business Background

Supercomnet Technologies Bhd is principally involved in the manufacturing of Polyvinyl chloride (PVC) compound and cables and wires for electronic devices and data control switches. The firm’s product portfolio comprises automobile plug-in cables, copper and jumper wires, cords and cord sets, LAN cable assemblies, and a full range of computer data cables. The company’s operations are located in Malaysia.
Analyze this stock with MQ Trader system

  7 people like this.
 
Jonathan Keung The board { supercomnet } more gear towards running factory operations. AGM discussion not their cup of tea. Just my own observation.
07/09/2021 6:35 AM
wallstreetrookie JP Morgan - Overweight on Supercomnet and sees greater upside in Mid-2021 Malaysia Small and Mid Cap Companies report
10/09/2021 6:04 PM
Mr.Sm Invest123 *SCOMNET 2Q21 Briefing Notes*

*2Q21 Results*

- 2Q21 revenue +36% yoy, PAT -9% yoy due to lower margin products and factory closure of 7days(Covid). PAT margin

- Revenue breakdown: SMP 69%,STB 26%, SAC 5%

- Restricted workforce capacity due to MCO3.0 resulted in revenue -13% qoq, but PAT +11% on effective cost savings and resolved freight/raw material cost hike in 1Q21.

- SMP and STB only allowed to operate on a 60% workforce from 24 May to 31 Aug, SAC 10%. But able to achieve 80% to 90% of total output despite lower workforce.

- Orders made by Edward Lifesciences and Ambu have been increasing steadily.

- Able to complete second dose of vaccination for all employees by mid-Sept. Miti has also granted Scomnet to run on 100% workforce from 1st Sept as the vaccination rate has already reached over 85%.

- Cost structure: Raw material 71% (1Q:76%), labour 16% (1Q14%), overhead 13% (1Q:10%)

*Key Reviews*

- Net margin: SMP: 25-35%, STB: 8-15%, SAC: 12-18%, currently implementing Lean Manufacturing for effective cost control, and introducing new automation to replace existing manual processes and reducing quality rejects.

- Current production capacity: SMP 95%, STB %, SAC 35% fuel tank & 50% harness. (Assuming 100% workforce)

- Cost issues resolved in 2Q21. For copper prices, customers agreed to charge based on monthly LME quote instead of quarterly. For freight cost, customers agreed to pay for extra container allocation cost.

- For freight cost, talked to Edwards as one to two container/week send to Dominican. Initial quotation is USD2800/container until last month USD13k. Edwards took up all. If the parts are sent by air shipment, all paid by customer as well.

- For copper, ApTIV use a lot copper, and margin for aptiv quite low. For aptiv start with monthly adjustments, cost transferred to clients.

- About 20-25% production is currently under automation process. In the midst of shifting towards higher automation.

*Expansion Plan*

- Current capacity at 32392 sqm, housed in 4 factories with total BU of 17308 sqm, STB 40%, SAC 15% and 45% respectively.

- 5-storey Building: RM10m capex, completion 3 years from commencement date. 2nd floor Expansion: Completed in Feb, added 360 spm. Further expansion on 2nd floor: Completing Jan 2022, +15-20% production capacity.


*Business Outlook*

- SMP affected due to halted orders of Mermaid, expect to commence their new product orders again in September. D*Clot HD, is now cleared by FDA and pending CE approval for the European markets. Expect a five figures' orders per annum for this D Clot HD. D Clot OTW pending both CE and FDA approval (better sales than HD, starting late 2022).

- Plass expected to obtain FDA approval in Q4, thus the orders will show in 4Q21 or 1Q22 onwards. Once they get it, 1st customer for Plass are the US special forces. Even if FDA approval not cleared, they’ll purchase 5-figures unit, regardless.

- If Plass cleared FDA, Defence Department of US will purchase millions units as it is the new standard of care in military medicine. Plass’ 2nd customer will be US Navy Marines. Every purchase of 3k Plass bullets, will require 1 Plass device. Group’s tooling setup is 40k units per month.

- Plass also approached by European Automotives to have 1 Plass device inside every car’s first-aid box. Didn’t get actual forecast, Plass keeps as secret and will only reveal once they obtained the FDA approval.

- STB remain unchanged.

- SAC will move after success of Fuel Tank and Wire Harness 1st localization mass production. Peugeot signed and delivered fuel tank. Expect to start the mass production of Fuel Tank in Dec 2021 and Wire Harness in Jul 2022. Nevertheless, LVA project(import from China) will continue until mass production success. LVA Project: Currently import from Wuhan (Peugeot approved vendor), and SAC assembles whatever Wuhan can produce.

- For SAC, can’t see the contribution in 2Q21 because of MCO, only customer for SAC is PSA. There is big potential for SAC to easily overtake STB revenue, because SAC ASP for wire harness is almost RM4k per vehicle, fuel tank is RM1-2k per vehicle.

- As per agreement, there is total 5 models with SAC. Currently initial stage on localization Stage 1 for Peugeot 3008 and 5008 fuel tanks and wire harness. Coming in addition will be 308 model right after this localization stage 1 complete and 1 more model which is due to Pakistan exports assembled in Naza.
10/09/2021 6:33 PM
Mr.Sm Invest123 *2021 Outlook*

- Expecting to see another double digit growth for FY2021.

- Catalyst 1: Production for new products such as Rotational Thrombectomy Device, Fuel Tank localization, oximetry sensors, wound occluder and Insertion Tube.

- Catalyst 2: Increased orders from existing customers, orderbook received mid-2022. More demand from clients not just for cardiovascular, stroke and respiratory devices, but also tactical military medical devices ad Tubing delivery system.

- Catalyst 3: Main board transfer by Oct this year and complete within 12 months

*Q&A:*
1. Discussed with APTIV, at this moment continue to supply for both proton and perodua until feb/march next year. From there onwards, will switch 45% of their PO (proton) to Tawin, only doing Perodua. For PSA, wire harnessing localisation starting July 2022 due to technical assistant in China not allowed to come Malaysia(Covid & MCO). For PSA, role wire sold to SAC is about 15% compared to APTIV 5-8% margin.

2. For Mermaid’s D Clot, initial projection 4000/month, then 10k/month followed by 40k/month. Production capacity of 10k/month in clean room is ready, but due to pandemic Mermaid unable to introduce its product. 2Q21 only 1000 pieces instead of 4k/month.

- Proceeded to obtain CE certification for D Clot HD as Europe demand higher than US. (CE mark know more detail in 7th Oct). FDA cert received earlier but CE cert was screwed previously, and they changed the new PIC and regulatory PIC for CE. Confident to receive in Oct.

3. For Ambu, Falcon CI and GI to Jan 2022, as they are facing issued with Falcon D (produced in German, faced technical issue in producing, thus have to improved all CI,GI, DI together, change the tooling). The testing quantity is still there, but commercial launching delayed to Jan 22.Ambu already become largest customer mainly due to insertion tube.

4. For Edwards, there’s a new product Oximetry sensor, took almost 2 years for design input. Official PO received, submitted to FDA and completed validations. The whole project about 5 years for 100k units. Every unit about USD125.

5. Orderbook: For SMP, on hand PO about 30% more than 2020 for until end of 2021. For SAC, PSA resumed back, will start to deliver fuel tank and harness, will have something there. STB remain unchanged.

6. Ambu became biggest revenue contributor to SMP, mainly due to endoscope’s insertion tube where demand increased. Besides in Penang, Ambu has second plant that produce complete endoscope in Mexico(new factory), and have to purchase their part from SMP as tied to FDA. Secondly, Although Falcon’s insertion tube extended launching to Jan 2022, SMP started delivering some to Ambu. The PO received until end of this year.

7. For Ambu endoscope increased, ASP +5% price on end-March to cover copper price surge. Edwards DPT price also increased(Sept/3Q21 onwards). Volume for Ambu endoscope 10k/day until March next year, then 13-14k/day start from April next year.
- In 1Q21, say ambu contribute 35% of revenue, about 10% of it is from endoscope. Even though without covid, this product continues to run and Ambu mentioned that this volume will be remained although no covid as it is used in other parts of body.

8. SMP revenue breakdown: Ambu about 56%, Edwards 42%, others: 2%. Plass will wait for FDA approval in 4Q21, and mermaid waiting commercial production in 2022.

9. Much stronger 2H coming forward, Ambu and Edwards much stronger. A few new products that are going to be introduced in 3Q, obtained another new FDA and CE, high demand. Secured another new client for SMP from US, sample stage completed, nearly have this in pipeline(Oct?). 2nd new product submitted to CE and FDA(new technology). 3rd new product: heat cutting knife?

10. New Customer: US customer moving out from HK due to China affiliated. Forecast will only announce in 3Q. Tooling and machinery are consigned, most technology are already being used by Scomnet. Parts require high precisions, tried other companies but only Scomnet achieved it. Scomnet will do full assembly with label.
10/09/2021 6:33 PM
Mr.Sm Invest123 next TP RM2,60
10/09/2021 6:35 PM
Jonathan Keung Transfer to Main Board next month good catalyst
10/09/2021 8:37 PM
Mr.Sm Invest123 HOPE TOO
10/09/2021 10:38 PM
kwcheong3888 good growth prospect ahead, company has a management of unquestionable integrity and wide economic moat
10/09/2021 11:02 PM
gohfredd Thanks Mr.Sim Invest123 for the valuable information… just curious where you got all those information:>
11/09/2021 10:36 AM
dchin472 best stock in bursa high growth
11/09/2021 10:37 AM
Mr.Sm Invest123 I HOLD FOR LONG TERM
11/09/2021 2:43 PM
Mr.Sm Invest123 R&D >>>>>> Samples >>>>>>FDA approval. Normally It take over 2-5 years for Medical devices samples approval.

Scomnet really endured/patients in the past & FINALLY fruitful
11/09/2021 2:54 PM
wallstreetrookie Agree with Mr.Sm Invest 123
12/09/2021 8:17 AM
calvinfong_them Mr. Sim
May i know what is the expected target price?
12/09/2021 8:07 PM
Mr.Sm Invest123 but 4 long term RM2.50-RM3 should be no problem
12/09/2021 11:06 PM
wallstreetrookie Don't miss out. This company is both healthcare and electronic small cap company.
13/09/2021 9:13 AM
wallstreetrookie Mr. Sm's price target of RM2.5 will be reached in days
13/09/2021 9:13 AM
wallstreetrookie If the company does well, it will soon be listed in the Main Market. Then the stock will literally skyrocket
13/09/2021 9:15 AM
FreshNoob Pump and dump ?
13/09/2021 9:22 AM
investortrader88 At last it fly.good luck guys.
13/09/2021 9:32 AM
cherry88 If we refer to UOB research dated 6/9, its TP is RM2.15. This is based on 32x PE of next year PE. However, if you can hold a little longer, say 2 more years, and based on Healthcare Index's 5-year mean of 44x, you could expect RM4.40 (Based on FY2023 EPS of 10sen with PE of 44x). Although this company is a small little company, if you look at its Top30 shareholdings, other than the directors' holdings, other top 30 shareholders are all institutional funds (mainly Public, Affin, Kenanga). Top30 accounted 74% of the total issued shares.
UOB is rather conservative as it did not take in the additional 100% capacity expansion on its 5-floor buiding which to be completed in 3 years. Again, if you can even longer, I can expect its TP to hit RM8.80 ! Why, because this company product is almost "monopoly" and only can produce by them (with FDA approval). And the single-use endoscope will be the "future trend" due to the COVID risk. Hospital will be replace this single-use from re-useable endoscope.
The company profile will be highlighted again once it transfer to Main Board in the 2nd half of the year later....So, BUY while still cheap
13/09/2021 9:40 AM
cherry88 Correction : The company is scheduled to transfer to Main Board in 2nd half of next year !
13/09/2021 9:46 AM
wallstreetrookie Don't just buy a company because of the institutional holdings. This is bad habit for investing lmao. High institutional ownership like Top Glove last year is a harbinger of bad things to come. When institutions own the majority of the float, there is not much upside. This company, however, has this unique moat.
13/09/2021 9:52 AM
cherry88 @wallstreetrookie.....agreed. We should focus on its future growth
13/09/2021 10:07 AM
Mr.Sm Invest123 i bought 3 years ago & hold for long term investment
13/09/2021 1:42 PM
cherry88 wah...u really can tahan !
13/09/2021 3:57 PM
Mr.Sm Invest123 confident in this company
13/09/2021 5:20 PM
calvinfong_them Mr. Sim Invest123
May i know what is the price you bought 3 years ago?
14/09/2021 8:52 AM
FreshNoob @mr.sm invest.

Wah. Then u must be really frustrated.. see it climb all the way up to 2 plus and drop back all the way down so many times already . Haha
14/09/2021 9:29 AM
Mr.Sm Invest123 calvinfong_them @ ard 35 cents
14/09/2021 12:20 PM
cherry88 Another Warren Buffee was born... LOL
14/09/2021 1:20 PM
Mr.Sm Invest123 cherry88 yes
14/09/2021 4:00 PM
Jonathan Keung Go for long term growth stocks but buy and hold strategy might not work for everyone.unless you have 2-3 years holding power. This applies to most retailers { short term in nature }
15/09/2021 10:58 AM
Mr.Sm Invest123 FreshNoob@ I am never frustrated
16/09/2021 8:22 PM
22/09/2021 2:49 PM
cherry88 guys n gals.....start to look excited....next immediate TP should be RM2.00
22/09/2021 2:57 PM
Mr.Sm Invest123 cherry88@next immediate TP should >be RM2.00-2.50
22/09/2021 6:54 PM
cherry88 Haha....Cherry is very conservative....Anyway, this cherry remains fresh and will still hold on
23/09/2021 8:41 AM
FreshNoob Wow ! Alot of strength..
23/09/2021 9:39 AM
cherry88 Cherry still green, and isn't ripe yet. Please buy back and keep before it is sold out
23/09/2021 10:45 AM
Mr.Sm Invest123 accumulating.......
25/09/2021 9:40 PM
FreshNoob Wow. Down to the ground and fly to the moon !
27/09/2021 11:38 AM
cherry88 Pls refer to my comment dated 13/9, and do your own research. It is still "on the ground", just floating a bit only
27/09/2021 12:36 PM
Jonathan Keung Hit $1.91 now ease back { no holding power }
28/09/2021 11:21 AM
pandaemonaeon What happen?drop too much today
28/09/2021 8:04 PM
FreshNoob Wheres next support level
29/09/2021 4:16 PM
cherry88 Every current price level is the support level, as it is already "floating on the ground". the only direction is up.
01/10/2021 10:08 AM
Plantermen Need to wait for the coming main board transfer
11/10/2021 12:13 PM
MrWinMoney Any ETA for that?
11/10/2021 2:09 PM
cherry88 Refer to my earlier comments dated 13/9, UOB has given a TP of RM2.15 based on 32x PE. However, I expect a higher TP if you can hold a bit longer, to achieve a TP of RM4.40 (based on industry PE of 40x)
20/10/2021 2:20 PM


TOP ARTICLES

1. HUGE POTENTIAL EARNINGS AHEAD FOR THIS CO !!! A POTENTIAL TAKEOVER TARGET ??? Bursa Master
2. Serba Dinamik securities trade suspended from 2.30pm on Friday until further notice save malaysia!
3. “Serba’s indefinite trading suspension to stay till release of SIR findings” save malaysia!
4. NOW SHOWING : THE TRILOGY OF FAST & FURIOUS SHOW - PART 13 A - SUPER BULL STOCKS - Super Positive Momentum Stocks - FOR 25 OCTOBER 2021 --- KGB & K SEE_Research
5. NOW SHOWING : THE TRILOGY OF FAST & FURIOUS SHOW - PART 13 SUPER BULL STOCKS -Super Positive Momentum Stocks -FOR 22 OCTOBER 2021 --- KGB & KGB W SEE_Research
6. Palm Oil: The Investment of Successful Gurus like Dr. Neoh Soon Kean of Dynaquest, Fong Siling aka Cold Eye & Robert Kuok, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
7. Vietnam to open Phu Quoc island to vaccinated tourists in November Good Articles to Share
8. THREE-A RESOURCES BERHAD [0012] - UNDERVALUE STOCK THAT YOU SHOULD PAY ATTENTION The Thinker Touch
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

441  399  636  801 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SERBADK 0.35-0.02 
 SAPNRG 0.1050.00 
 OPCOM 1.33+0.20 
 VC 0.09+0.01 
 KNM 0.220.00 
 JADI 0.10-0.01 
 THETA 1.32+0.18 
 NWP 0.29-0.005 
 HIAPTEK 0.64-0.01 
 SCIB 0.405-0.025 
PARTNERS & BROKERS